Gyon Technologies Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,417
Closed -$396K 518
2022
Q2
$396K Sell
4,417
-1,043
-19% -$106K 0.11% 206
2022
Q1
$606K Buy
+5,460
New +$577K 0.43% 80
2021
Q4
Sell
-14,179
Closed -$1.78M 613
2021
Q3
$1.78M Sell
14,179
-8,973
-39% -$1.16M 0.48% 71
2021
Q2
$2.87M Buy
23,152
+9,193
+66% +$1.15M 0.94% 10
2021
Q1
$1.65M Sell
13,959
-9,571
-41% -$1.12M 0.72% 23
2020
Q4
$2.76M Buy
23,530
+11,220
+91% +$1.24M 0.95% 18
2020
Q3
$1.28M Buy
+12,310
New +$1.24M 1% 9
2020
Q2
Sell
-3,350
Closed -$302K 119
2020
Q1
$302K Buy
+3,350
New +$356K 0.58% 62

Other funds holding MDT

Gyon Technologies Capital Management's MDT Position: Q3 2022 in Review

Gyon Technologies Capital Management sold out of Medtronic (MDT) in Q3 2022, closing a stake of 4,417 shares — an estimated $396K sold.

Gyon Technologies Capital Management first reported a position in MDT in Q1 2020 and held it in 8 quarters. The position peaked at $2.87M in Q2 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Gyon Technologies Capital Management reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 4,417 Medtronic shares in Q3 2022, an estimated $396K.
  • Gyon Technologies Capital Management first reported a position in Medtronic in Q1 2020 and held it in 8 quarters.
  • Gyon Technologies Capital Management's Medtronic position peaked at $2.87M in Q2 2021.
  • 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.